FastTRK is a clinical testing program for the diagnosis of NTRK gene fusions. Sponsored by Bayer, this is a complimentary service for clinicians to determine whether their patients’ cancer has an NTRK gene fusion.
Eligibility criteria includes ALL patients with solid tumours that are metastatic or ...
UPDATE: EXTENDED TO MARCH 31, 2022
IMPORTANT UPDATE FOR PATIENTS AND CLINICS IN ONTARIO ONLY
New, temporary criteria for Non-Invasive Prenatal Testing in Ontario will improve access to NIPT: The COVID-19 crisis has reduced patient access to ultrasounds for nuchal translucency measurement used along with the enhanced first trimester screen ...
When planning for a family, you may want to take a screening test. In the New York Times article, "Everything You Need to Know About Blood Tests During Pregnancy" doctors recommend pregnant women get certain blood tests to reveal information on the health of their baby. Two of these tests are ...
According to a recent paper published in the American Journal of Human Genetics, one out of every 100 European couples is at risk of having a child affected with an autosomal-recessive (AR) genetic condition. Genes are passed on from parent to child therefore we have two copies of each gene. ...
Non-Invasive Prenatal Testing 
Signatera 
Search for a Test 
